Skip to Content

Corix Bioscience Inc CXBS

Morningstar Rating
$0.00 0.00 (99.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CXBS is trading at a 57% discount.
Price
$0.00
Fair Value
$4.89
Uncertainty
Extreme
1-Star Price
$3.23
5-Star Price
Economic Moat
Yctd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CXBS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.25
Bid/Ask
/
Market Cap
$27.34
Volume/Avg
4,059 / 4,530

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
2

Valuation

Metric
CXBS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CXBS

Financial Strength

Metric
CXBS
Quick Ratio
0.46
Current Ratio
5.11
Interest Coverage
−10.51
Quick Ratio
CXBS

Profitability

Metric
CXBS
Return on Assets (Normalized)
−40.10%
Return on Equity (Normalized)
−96.74%
Return on Invested Capital (Normalized)
−38.05%
Return on Assets
CXBS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYwywdwznRltt$70.0 Bil
MKKGY
Merck KGaA ADRZqvpzlrzgCmdzjcb$67.6 Bil
HLN
Haleon PLC ADRQzvdxtxkbDyd$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRYsdwjcnGqwy$14.3 Bil
VTRS
Viatris IncXsvvjpnxxMfpp$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYvltjxjNrkk$11.9 Bil
CTLT
Catalent IncJndkqpkGtrqxfl$10.0 Bil
PRGO
Perrigo Co PLCYffsxhdxDmf$4.1 Bil
CURLF
Curaleaf Holdings IncWplhwlmvVqyth$3.6 Bil
PBH
Prestige Consumer Healthcare IncVjmgdjnfFnmmbdc$3.4 Bil

Sponsor Center